(Q81861020)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15961350%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Patient and physician reactions to generic antiepileptic substitution in the treatment of epilepsy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15961350%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

Lisa S Haskins

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15961350%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Kenneth J Tomaszewski

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15961350%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Pamela Crawford

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15961350%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

publication date

1 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15961350%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15961350%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15961350%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15961350%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

98-105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15961350%20AND%20SRC:MED&resulttype=core&format=json

Generic substitution for brand name antiepileptic drugs: a survey.

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.04.005

Carbamazepine toxicity resulting from generic substitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.04.005

Loss of seizure control associated with generic substitution of carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.04.005

Physicians underestimate the frequency of generic carbamazepine substitution: results of a survey and review of the problem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.04.005

Comparative bioavailability of a generic phenytoin and Dilantin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.04.005

The relative bioavailability and in vivo-in vitro correlations for four marketed carbamazepine tablets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.04.005

A multiple-dose safety and bioequivalence study of a narrow therapeutic index drug: a case for carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.04.005

Therapeutic equivalency of generic antiepileptic drugs: results of a survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.04.005

Breakthrough seizure following substitution of Depakene capsules (Abbott) with a generic product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2005.04.005

10.1016/J.YEBEH.2005.04.005

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15961350%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

1 reference